Financial Year |
March 31 2023 |
Monetary Funds |
263,403,231.57 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
110,659,366.93 |
Accounts Receivable |
186,172,969.15 |
Advances to Suppliers |
21,561,598.04 |
Other Receivables |
7,795,694.64 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
231,640,541.33 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
28,665,858.05 |
Total Current Assets |
868,569,016.74 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
251,113,228.27 |
Under-construction Projects |
199,612,485.72 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
11,744,703.46 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
57,656,762.70 |
Deferred Income Tax Assets |
59,434,069.94 |
Other Non-Current Assets |
63,433,451.28 |
Sub-Total of Non-Current Assets |
735,972,595.51 |
Total Assets |
1,604,541,612.25 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
25,070,324.72 |
Accounts Payable |
116,043,381.48 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
19,691,213.94 |
Taxes Payable |
8,207,534.13 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
65,458,035.02 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
24,462,679.03 |
Other Current Liabilities |
44,557,128.16 |
Sub-Total of Current Liabilities |
428,167,023.95 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
41,917,994.79 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
195,937,540.76 |
Total Liabilities |
624,104,564.71 |
Paid-In Capital(Or Share Stock) |
255,010,000.00 |
Capital Surplus |
341,770,536.10 |
Surplus Reserve |
43,840,176.24 |
LESS:Treasury Stock |
57,067,800.00 |
Undistributed Profits |
373,483,011.31 |
Minority Stockholder's Interest |
23,650,077.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
956,786,970.54 |
Owner's Equity(Stockholder's Equity) |
980,437,047.54 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,604,541,612.25 |